Literature DB >> 22474311

Clinical and genetic determinants of torsade de pointes risk.

Andrew J Sauer1, Christopher Newton-Cheh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22474311      PMCID： PMC3347483          DOI： 10.1161/CIRCULATIONAHA.111.080887

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  119 in total

1.  KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.

Authors:  Lia Crotti; Andrew L Lundquist; Roberto Insolia; Matteo Pedrazzini; Chiara Ferrandi; Gaetano M De Ferrari; Alessandro Vicentini; Ping Yang; Dan M Roden; Alfred L George; Peter J Schwartz
Journal:  Circulation       Date:  2005-08-22       Impact factor: 29.690

2.  Nontranscriptional regulation of cardiac repolarization currents by testosterone.

Authors:  Chang-Xi Bai; Junko Kurokawa; Masaji Tamagawa; Haruaki Nakaya; Tetsushi Furukawa
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

3.  Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study.

Authors:  Arne Pfeufer; Shapour Jalilzadeh; Siegfried Perz; Jakob C Mueller; Martin Hinterseer; Thomas Illig; Mahmut Akyol; Cornelia Huth; Andreas Schöpfer-Wendels; Bernhard Kuch; Gerhard Steinbeck; Rolf Holle; Michael Näbauer; H-Erich Wichmann; Thomas Meitinger; Stefan Kääb
Journal:  Circ Res       Date:  2005-03-03       Impact factor: 17.367

Review 4.  Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.

Authors:  Rashmi R Shah; Luc M Hondeghem
Journal:  Heart Rhythm       Date:  2005-07       Impact factor: 6.343

Review 5.  Animal models for arrhythmias.

Authors:  David J Milan; Calum A MacRae
Journal:  Cardiovasc Res       Date:  2005-08-15       Impact factor: 10.787

6.  Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death.

Authors:  Sabine M J M Straus; Miriam C J M Sturkenboom; Gysèle S Bleumink; Jeanne P Dieleman; Johan van der Lei; Pieter A de Graeff; Jan Herre Kingma; Bruno H Ch Stricker
Journal:  Eur Heart J       Date:  2005-05-11       Impact factor: 29.983

Review 7.  Long QT syndrome: reduced repolarization reserve and the genetic link.

Authors:  D M Roden
Journal:  J Intern Med       Date:  2006-01       Impact factor: 8.989

8.  Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.

Authors:  Bertram Pitt; Harvey White; Jose Nicolau; Felipe Martinez; Mihai Gheorghiade; Michael Aschermann; Dirk J van Veldhuisen; Faiez Zannad; Henry Krum; Robin Mukherjee; John Vincent
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

9.  In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine.

Authors:  Yunlong Xia; Yanchun Liang; Ole Kongstad; Qiuming Liao; Magnus Holm; Bertil Olsson; Shiwen Yuan
Journal:  Heart Rhythm       Date:  2005-02       Impact factor: 6.343

10.  Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks.

Authors:  Allen Burke; Wendy Creighton; Erik Mont; Ling Li; Susan Hogan; Robert Kutys; David Fowler; Renu Virmani
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690
View more
  33 in total

Review 1.  Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Karim Sallam; Yingxin Li; Philip T Sager; Steven R Houser; Joseph C Wu
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 2.  Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.

Authors:  Galia Jackobson; Narin Nard Carmel; Dor Lotan; Anjelika Kremer; Dan Justo
Journal:  Z Gerontol Geriatr       Date:  2016-11-22       Impact factor: 1.281

Review 3.  Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.

Authors:  Arsen Uvelin; Jasmina Pejaković; Vesna Mijatović
Journal:  J Anesth       Date:  2017-02-22       Impact factor: 2.078

4.  Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting.

Authors:  Keith A Marill; Emily S Miller
Journal:  J Electrocardiol       Date:  2017-02-10       Impact factor: 1.438

Review 5.  Pharmacological treatment of acquired QT prolongation and torsades de pointes.

Authors:  Simon H L Thomas; Elijah R Behr
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

6.  Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study.

Authors:  Sylvain Goutelle; Elodie Sidolle; Michel Ducher; Jacques Caron; Quadiri Timour; Patrice Nony; Aurore Gouraud
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

Review 7.  Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Transl Res       Date:  2012-09-17       Impact factor: 7.012

8.  Interleukin-1β gene variants are associated with QTc interval prolongation following cardiac surgery: a prospective observational study.

Authors:  Miklos D Kertai; Yunqi Ji; Yi-Ju Li; Joseph P Mathew; James P Daubert; Mihai V Podgoreanu
Journal:  Can J Anaesth       Date:  2016-02-08       Impact factor: 5.063

Review 9.  Human-induced pluripotent stem cell models of inherited cardiomyopathies.

Authors:  Ioannis Karakikes; Vittavat Termglinchan; Joseph C Wu
Journal:  Curr Opin Cardiol       Date:  2014-05       Impact factor: 2.161

10.  Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports.

Authors:  W Victor R Vieweg; Jules C Hancox; Mehrul Hasnain; Jayanthi N Koneru; Michael Gysel; Adrian Baranchuk
Journal:  Ther Adv Infect Dis       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.